Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 4/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24409044 | 0.89 | KMT2A (0.33) | KMT2AMEN1POLBNPC1 | |
| SCHEMBL24409175 | 0.84 | NPC1 (0.34) | KMT2AMEN1POLBNPC1 | |
| SCHEMBL24409283 | 0.82 | KMT2A (0.32) | FABP7FABP5KMT2AMEN1 | |
| SCHEMBL10119911 | 0.78 | FABP7 (0.45) | FABP7FABP5 | |
| SCHEMBL963171 | 0.78 | KMT2A (0.38) | KMT2AMEN1POLBNPC1 | |
| SCHEMBL24409171 | 0.78 | NPC1 (0.33) | NPC1 | |
| SCHEMBL24409041 | 0.78 | SLC6A4 (0.31) | — | |
| SCHEMBL24409166 | 0.76 | RXRA (0.33) | FABP7FABP5RXRARXRB | |
| SCHEMBL12920508 | 0.76 | KMT2A (0.35) | KMT2AMEN1POLBNPC1 | |
| SCHEMBL12009850 | 0.76 | NPSR1 (0.41) | KMT2AMEN1POLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220146931-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146931-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, FGFR1, CLIC1 | FABP7 1098/4885FABP5 809/4885KMT2A 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.